|
Market Closed -
Nasdaq
00:00:00 22/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.910 USD | -1.57% |
|
+3.44% | -9.90% |
| 16/06/25 | Crescent Biopharma Completes Merger With GlycoMimetics | MT |
| 30/10/23 | Catalyst Biosciences, Inc.(NasdaqCM:CBIO) dropped from NASDAQ Composite Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E |
|---|
- Stock Market
- Stocks
- CBIO Stock
- Charts Catalyst Biosciences
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
